2025-08-29 06:24:46
Latest Post
Himadri Speciality Chemical Ltd Secures ISCC PLUS Certification
HCLSoftware delivers Digital Independence with AI-Powered Sovereign Collaboration Solutions for Business-Critical Infrastructure
Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited announce Merger
SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
Rail Vikas Nigam Ltd signs JV agreement with Texmaco Rail & Engineering Ltd
Stock Report
Krebs Biochemicals and Industries Ltd posts loss of Rs. 6.93 crores in Q4 FY2023
Posted On : 2023-05-24 18:45:56( TIMEZONE : IST )
Krebs Biochemicals and Industries Limited has reported Standalone financial results for the period ended March 31, 2023.
Financial Results (Q4 FY2023) - QoQ Comparison
The company has reported total income of Rs. 11.6538 crores during the period ended March 31, 2023 as compared to Rs. 9.1136 crores during the period ended December 31, 2022.
The company has posted net profit / (loss) of Rs. -6.9397 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. -5.5543 crores for the period ended December 31, 2022.
The company has reported EPS of Rs. -3.07 for the period ended March 31, 2023 as compared to Rs. -2.58 for the period ended December 31, 2022.
| Financials | Q4 FY2023 | Q3 FY2023 | % Change |
| Total Income | ₹11.6538 crs | ₹9.1136 crs |  27.87% |
| Net Profit | ₹-6.9397 crs | ₹-5.5543 crs |  24.94% |
| EPS | ₹-3.07 | ₹-2.58 | 18.99% |
Financial Results (Q4 FY2023) - YoY Comparison
The company has reported total income of Rs.11.6538 crores during the period ended March 31, 2023 as compared to Rs.19.9503 crores during the period ended March 31, 2022.
The company has posted net profit / (loss) of Rs.-6.9397 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.-11.3139 crores for the period ended March 31, 2022.
The company has reported EPS of Rs.-3.07 for the period ended March 31, 2023 as compared to Rs.-5.39 for the period ended March 31, 2022.
| Financials | Q4 FY2023 | Q4 FY2022 | % Change |
| Total Income | ₹11.6538 crs | ₹19.9503 crs |  -41.59% |
| Net Profit | ₹-6.9397 crs | ₹-11.3139 crs |  38.66% |
| EPS | ₹-3.07 | ₹-5.39 | 43.04% |
Financial Results (Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.52.7546 crores during the Financial Year ended March 31, 2023 as compared to Rs.60.8589 crores during the Financial Year ended March 31, 2022.
The company has posted net profit / (loss) of Rs.-24.6919 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.-44.5268 crores for the Financial Year ended March 31, 2022.
The company has reported EPS of Rs.-11.30 for the Financial Year ended March 31, 2023 as compared to Rs.-20.81 for the Financial Year ended March 31, 2022.
| Financials | Year Ended FY2023 | Year Ended FY2022 | % Change |
| Total Income | ₹52.7546 crs | ₹60.8589 crs | -13.32% |
| Net Profit | ₹-24.6919 crs | ₹-44.5268 crs | 44.55% |
| EPS | ₹-11.30 | ₹-20.81 | 45.70% |
Shares of Krebs Biochemicals and Industries Limited was last trading in BSE at Rs. 67.77 as compared to the previous close of Rs. 67.03. The total number of shares traded during the day was 612 in over 12 trades.
The stock hit an intraday high of Rs. 67.77 and intraday low of 66.06. The net turnover during the day was Rs. 41143.00.
